Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Seasonale for treating low bone mineral density (osteopenia) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia

Drugs mentioned

• Seasonale (ethinyl estradiol / drospirenone)

Snippet

Sponsor: Duramed Research | Conditions: Osteopenia | Phase 3 | Status: WITHDRAWN